Literature DB >> 20955917

Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies.

Rebecca A Keel1, Christina A Sutherland, Jaber Aslanzadeh, David P Nicolau, Joseph L Kuti.   

Abstract

We examined the potential correlation between vancomycin and daptomycin MIC for 298 Staphylococcus aureus by broth microdilution (BMD), Etest, and MicroScan(®). Etest and BMD identified a significant, albeit poor, correlation between MICs (ρ = 0.29, P < .01, and ρ = 0.15, P = .01, respectively), but no correlation (ρ = 0.08, P = .18) was observed with MicroScan.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20955917     DOI： 10.1016/j.diagmicrobio.2010.08.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  10 in total

1.  False daptomycin-nonsusceptible MIC results by Microscan panel PC 29 relative to Etest results for Staphylococcus aureus and enterococci.

Authors:  Elizabeth L Palavecino; Jacqueline M Burnell
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

2.  Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.

Authors:  Sanjiv M Baxi; Angelo Clemenzi-Allen; Alice Gahbauer; Daniel Deck; Brandon Imp; Eric Vittinghoff; Henry F Chambers; Sarah Doernberg
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.

Authors:  Y-H Chen; C-Y Liu; W-C Ko; C-H Liao; P-L Lu; C-H Huang; C-T Lu; Y-C Chuang; S-M Tsao; Y-S Chen; Y-C Liu; W-Y Chen; T-N Jang; H-C Lin; C-M Chen; Z-Y Shi; S-C Pan; J-L Yang; H-C Kung; C-E Liu; Y-J Cheng; J-W Liu; W Sun; L-S Wang; K-W Yu; P-C Chiang; M-H Lee; C-M Lee; G-J Hsu; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-18       Impact factor: 3.267

4.  Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Kara B Mascitti; Paul H Edelstein; Neil O Fishman; Knashawn H Morales; Andrew J Baltus; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2011-12-20       Impact factor: 3.254

5.  Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.

Authors:  Kyoung-Ho Song; Moonsuk Kim; Chung Jong Kim; Jeong Eun Cho; Yun Jung Choi; Jeong Su Park; Soyeon Ahn; Hee-Chang Jang; Kyung-Hwa Park; Sook-In Jung; Nara Yoon; Dong-Min Kim; Jeong-Hwan Hwang; Chang Seop Lee; Jae Hoon Lee; Yee Gyung Kwak; Eu Suk Kim; Seong Yeon Park; Yoonseon Park; Kkot Sil Lee; Yeong-Seon Lee; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

6.  High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.

Authors:  Jesse T Jacob; Carlos A DiazGranados
Journal:  Int J Infect Dis       Date:  2012-10-22       Impact factor: 3.623

7.  Evaluating vancomycin susceptibility in Staphylococcus aureus.

Authors:  Marcelo J Mimica; Alessandra Navarini
Journal:  Infect Drug Resist       Date:  2016-09-26       Impact factor: 4.003

8.  Increasing rate of daptomycin non-susceptible strains of Staphylococcus aureus in patients with atopic dermatitis.

Authors:  Izabela Błażewicz; Maciej Jaśkiewicz; Lidia Piechowicz; Damian Neubauer; Roman J Nowicki; Wojciech Kamysz; Wioletta Barańska-Rybak
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

Review 9.  New antibiotics for bad bugs: where are we?

Authors:  Matteo Bassetti; Maria Merelli; Chiara Temperoni; Augusta Astilean
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-08-28       Impact factor: 3.944

10.  Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range.

Authors:  Cameron J Phillips; Nicholas A Wells; Marianne Martinello; Simon Smith; Richard J Woodman; David L Gordon
Journal:  Infect Drug Resist       Date:  2016-05-31       Impact factor: 4.003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.